Science
Powering forward – Genomics England’s COVID-19 response – Drug Target Review
Thorben Seeger reveals how Genomics England’s next-generation genomic research platform will play a key role in the response to COVID-19.
Posted: 11 September 2020 | Nikki Withers (Drug Target Review) | No comments yet
Genomics England has launched a next-generation genomic research platform that will play a key role in the response to COVID-19. It is hoped this research environment will transform how genomic data is made usable for global biopharma and academic scientists, providing worldclass patient data security, while enabling the flexibility required at the cutting edge of science. Nikki Withers spoke to Thorben Seeger, who…
-
General23 hours agoAustralian economy still vulnerable to US bond turmoil
-
Noosa News17 hours agoMan shot in the leg during attempted break-in at Beenleigh, Queensland
-
Business21 hours ago2 ASX 200 shares that could be top buys for growth
-
General8 hours agoDemocratic senators want an investigation into potential market manipulation from Trump’s inner circle